Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts

被引:17
作者
Kittaka, Mizuho [1 ,2 ]
Yoshimoto, Tetsuya [1 ,2 ]
Schlosser, Collin [3 ]
Rottapel, Robert [4 ]
Kajiya, Mikihito [5 ]
Kurihara, Hidemi [5 ]
Reichenberger, Ernst J. [6 ]
Ueki, Yasuyoshi [1 ,2 ]
机构
[1] Indiana Univ, Sch Dent, Dept Biomed Sci & Comprehens Care, Indianapolis, IN 46202 USA
[2] Indiana Univ, Indiana Ctr Musculoskeletal Hlth, Sch Med, Indianapolis, IN 46202 USA
[3] Univ Missouri, Sch Dent, Dept Orthodont & Dentofacial Orthoped, Kansas City, MO USA
[4] Univ Toronto, Dept Med Immunol & Med Biophys, Toronto, ON, Canada
[5] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Inst Biomed & Hlth Sci, Dept Periodontal Med,Appl Life Sci, Hiroshima, Japan
[6] Univ Connecticut Hlth, Sch Dent Med, Dept Reconstruct Sci, Farmington, CT USA
基金
美国国家卫生研究院; 日本学术振兴会;
关键词
PERIODONTITIS; SH3BP2; SYK; BONE LOSS; OSTEOCLASTS; TUMOR-NECROSIS-FACTOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; TYROSINE KINASE INHIBITOR; 3BP2 ADAPTER PROTEIN; EXPERIMENTAL PERIODONTITIS; CELL-ACTIVATION; ORAL BACTERIA; M-CSF; SYK; RECEPTOR;
D O I
10.1002/jbmr.3882
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Periodontitis is a bacterially induced chronic inflammatory condition of the oral cavity where tooth-supporting tissues including alveolar bone are destructed. Previously, we have shown that the adaptor protein SH3-domain binding protein 2 (SH3BP2) plays a critical role in inflammatory response and osteoclastogenesis of myeloid lineage cells through spleen tyrosine kinase (SYK). In this study, we show that SH3BP2 is a novel regulator for alveolar bone resorption in periodontitis. Micro-CT analysis of SH3BP2-deficient (Sh3bp2( -/-)) mice challenged with ligature-induced periodontitis revealed that Sh3bp2( -/-) mice develop decreased alveolar bone loss (male 14.9% +/- 10.2%; female 19.0% +/- 6.0%) compared with wild-type control mice (male 25.3% +/- 5.8%; female 30.8% +/- 5.8%). Lack of SH3BP2 did not change the inflammatory cytokine expression and osteoclast induction. Conditional knockout of SH3BP2 and SYK in myeloid lineage cells with LysM-Cre mice recapitulated the reduced bone loss without affecting both inflammatory cytokine expression and osteoclast induction, suggesting that the SH3BP2-SYK axis plays a key role in regulating alveolar bone loss by mechanisms that regulate the bone-resorbing function of osteoclasts rather than differentiation. Administration of a new SYK inhibitor GS-9973 before or after periodontitis induction reduced bone resorption without affecting inflammatory reaction in gingival tissues. In vitro, GS-9973 treatment of bone marrow-derived M-CSF-dependent macrophages suppressed tartrate-resistant acid phosphatase (TRAP)-positive osteoclast formation with decreased mineral resorption capacity even when GS-9973 was added after RANKL stimulation. Thus, the data suggest that SH3BP2-SYK is a novel signaling axis for regulating alveolar bone loss in periodontitis and that SYK can be a potential therapeutic target to suppress alveolar bone resorption in periodontal diseases. (c) 2019 American Society for Bone and Mineral Research. (c) 2019 American Society for Bone and Mineral Research.
引用
收藏
页码:382 / 395
页数:14
相关论文
共 69 条
[1]   Optimization of the ligature-induced periodontitis model in mice [J].
Abe, Toshiharu ;
Hajishengallis, George .
JOURNAL OF IMMUNOLOGICAL METHODS, 2013, 394 (1-2) :49-54
[2]   Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor [J].
AbuAmer, Y ;
Ross, FP ;
Edwards, J ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1557-1565
[3]   The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival [J].
Ainsua-Enrich, Erola ;
Serrano-Candelas, Eva ;
Alvarez-Errico, Damiana ;
Picado, Cesar ;
Sayos, Joan ;
Rivera, Juan ;
Martin, Margarita .
JOURNAL OF IMMUNOLOGY, 2015, 194 (09) :4309-4318
[4]   The Adaptor 3BP2 Is Required for Early and Late Events in FcεRI Signaling in Human Mast Cells [J].
Ainsua-Enrich, Erola ;
Alvarez-Errico, Damiana ;
Gilfillan, Alasdair M. ;
Picado, Cesar ;
Sayos, Joan ;
Rivera, Juan ;
Martin, Margarita .
JOURNAL OF IMMUNOLOGY, 2012, 189 (06) :2727-2734
[5]  
[Anonymous], 2004, J PERIODONTOL, V75, P1553
[6]   REQUIREMENT OF PP60C-SRC EXPRESSION FOR OSTEOCLASTS TO FORM RUFFLED BORDERS AND RESORB BONE IN MICE [J].
BOYCE, BF ;
YONEDA, T ;
LOWE, C ;
SORIANO, P ;
MUNDY, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1622-1627
[7]   Rare-disease genetics in the era of next-generation sequencing: discovery to translation [J].
Boycott, Kym M. ;
Vanstone, Megan R. ;
Bulman, Dennis E. ;
MacKenzie, Alex E. .
NATURE REVIEWS GENETICS, 2013, 14 (10) :681-691
[8]   R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation [J].
Braselmann, Sylvia ;
Taylor, Vanessa ;
Zhao, Haoran ;
Wang, Su ;
Sylvain, Catherine ;
Baluom, Muhammad ;
Qu, Kunbin ;
Herlaar, Ellen ;
Lau, Angela ;
Young, Chi ;
Wong, Brian R. ;
Lovell, Scott ;
Sun, Thomas ;
Park, Gary ;
Argade, Ankush ;
Jurcevic, Stipo ;
Pine, Polly ;
Singh, Rajinder ;
Grossbard, Elliott B. ;
Payan, Donald G. ;
Masuda, Esteban S. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03) :998-1008
[9]   A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor [J].
Burke, Russell T. ;
Meadows, Sarah ;
Loriaux, Marc M. ;
Currie, Kevin S. ;
Mitchell, Scott A. ;
Maciejewski, Patricia ;
Clarke, Astrid S. ;
Dipaolo, Julie A. ;
Druker, Brian J. ;
Lannutti, Brian J. ;
Spurgeon, Stephen E. .
ONCOTARGET, 2014, 5 (04) :908-915
[10]   The 3BP2 adapter protein is required for optimal B-cell activation and thyus-independent type 2 humoral response [J].
Chen, Grace ;
Dimitriou, Ioannis D. ;
La Rose, Jose ;
Ilangumaran, Subburaj ;
Yeh, Wen-Chen ;
Doody, Gina ;
Turner, Martin ;
Gommerman, Jennifer ;
Rottapel, Robert .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (08) :3109-3122